Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiaojing Anshen Fang is a Traditional Chinese Medicine (TCM) herbal formula developed by the Sichuan Integrative Medicine Hospital for the treatment of perimenopausal insomnia. The formula is specifically designed to address the TCM pattern of kidney Yin deficiency syndrome, which is characterized by a lack of cooling essence leading to 'internal heat' and subsequent sleep disturbances. Its therapeutic objectives are to regulate menstruation (Tiaojing) and calm the spirit (Anshen). In clinical research, the formula is being evaluated in perimenopausal women with sub-health insomnia, where its efficacy is compared against esazolam and warm needle moxibustion. The study utilizes infrared thermal imaging to provide objective visualization of the TCM concept 'Yin deficiency leads to internal heat' and to track the formula's impact on physiological heat distribution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tiaojing Anshen Fang.